Journal of Medicinal Chemistry p. 8801 - 8815 (2017)
Update date:2022-08-15
Topics:
Kaitsiotou, Helena
Keul, Marina
Hardick, Julia
Mühlenberg, Thomas
Ketzer, Julia
Ehrt, Christiane
Krüll, Jasmin
Medda, Federico
Koch, Oliver
Giordanetto, Fabrizio
Bauer, Sebastian
Rauh, Daniel
In modern cancer therapy, the use of small organic molecules against receptor tyrosine kinases (RTKs) has been shown to be a valuable strategy. The association of cancer cells with dysregulated signaling pathways linked to RTKs represents a key element in
View MoreContact:+86-27-87204219, +86-27-87215023
Address:2402, HuiGu Space-time Building, 8 Forest Road, East Lake Hi-Tech Development Zone
Tianjin Ingenochem Technology Co.,Ltd
Contact:+86-22-23677060
Address:Hitech Green Industry Park K2-9-602, Nankai district
Changde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Guangxi Shanyun Biochemical Science and Technology Co., Ltd
Contact:+86-0772--6828887
Address:#2 Industrial Park of Luzhai County, Liuzhou, Guangxi, China
Zibo Linzi Darong Fine Chemical Co., Ltd
Contact:86-532-67773200; 15689126900
Address:Qidu town,Linzi district,Zibo city,Shandong province,China
Doi:10.1016/j.tet.2007.03.044
(2007)Doi:10.1039/c6ob01198e
(2016)Doi:10.1007/s10593-011-0744-x
(2011)Doi:10.1007/BF00574792
(1984)Doi:10.1002/hlca.19490320130
(1949)Doi:10.1039/c2ob26828k
(2012)